1Research ProposalA Critical Evaluation on How Breast Cancer Screening Prevents Breast Cancer ComparedTo Women Who Do Not Receive Breast Cancer Screening(By Name)Institutional AffiliationCourse Number and NameInstructors NameAssignment Due Date
2Section 1Background of the studyIn the United States, women are significantly more likely to be diagnosed with breastcancer than any other type of cancer (Shieh et al., 2020). There are many different types of breastcancer, but the most common is invasive, which means it has spread beyond the breast tissue andinto surrounding tissues or organs (Ahmad, 2019). Invasive breast cancer can be classified asfollows: About 78% of all cases of invasive breast cancer are HER2-positive (a type of geneticmarker that helps doctors determine how likely a tumor is to spread). About 12% of all cases ofinvasive breast cancer are triple-negative (a type of genetic marker that doesn’t help doctorsdetermine how likely a tumor is to spread) (Ahmad, 2019). About 2% of all cases of invasivebreast cancer are BRCA-positive (a type of genetic marker that helps doctors determine howlikely a tumor is to spread).There are many different breast cancer screening tests, but mammography is the mostcommon. Mammography uses X-rays to take pictures of the breasts. A digital image(mammogram) can be saved to be reviewed later by a doctor. Mammography can identify sometypes of breast cancer before it becomes invasive, but it doesn’t always (Marinovich et al., 2018).Breast cancer treatments include surgery, radiation therapy, and chemotherapy. Surgery is themost common treatment for invasive breast cancer (Marinovich et al., 2018). It involvesremoving the tumor and any surrounding tissues or organs. Radiation therapy uses high-energywaves to kill the tumor cells. It is usually given after surgery. Chemotherapy is a group of drugsused to treat cancer. It can be given as a single treatment, in combination with radiation therapyor surgery, or over months or years.
3There is no one cure for breast cancer. However, treatments can often improve the qualityof life for people with the disease. Survival rates for invasive breast cancer vary depending onthe type and stage; but overall, most people survive it (Ahmad, 2019). About 10% of womendiagnosed with invasive breast cancer will die from the disease. However, the five-year survivalrate for women with invasive breast cancer is about 85%. That means about 15 out of 100women will be alive five years after being diagnosed with the disease. The five-year survival ratefor women who have early-stage breast cancer is about 80%. That means about 18 out of 100women will be alive five years after being diagnosed with the disease. About 5 out of 100women diagnosed with metastatic breast cancer (cancer that has spread to other parts of thebody) will survive five years. Some women may have long-term side effects from theirtreatment, but most do not.
Upload your study docs or become a
Course Hero member to access this document
Upload your study docs or become a
Course Hero member to access this document
End of preview. Want to read all 19 pages?
Upload your study docs or become a
Course Hero member to access this document